Fix, J.D., Neuroanatomy. 4th ed. 2008, Philadelphia, Pennsylvania, USA.
Abrams, P., et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn, 2009. 28: 287. https://www.ncbi.nlm.nih.gov/pubmed/19350662
Клинические рекомендации Российского общества урологов под редакцией Ю.Г. Аляева, – М – 2017 г.
Nosseir, M., et al. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn, 2007. 26: 228. https://www.ncbi.nlm.nih.gov/pubmed/16998859
Panicker, J.N., et al. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol, 2015. 14: 720. https://www.ncbi.nlm.nih.gov/pubmed/26067125
Tagliaferri, F., et al. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien), 2006. 148: 255
Marinkovic, S.P., et al. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol, 2001.: 359. https://www.ncbi.nlm.nih.gov/pubmed/11176374
Rotar, M., et al. Stroke patients who regain urinary continence in the first week after acute first-ever stroke have better prognosis than patients with persistent lower urinary tract dysfunction. Neurourol Urodyn, 2011. 30: 1315. https://www.ncbi.nlm.nih.gov/pubmed/21488096
Lobo, A., et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology, 2000. 54: S4. https://www.ncbi.nlm.nih.gov/pubmed/10854354
Grant, R.L., et al. First diagnosis and management of incontinence in older people with and without dementia in primary care: a cohort study using The Health Improvement Network primary care database. PLoS Med, 2013. 10: 1001. https://www.ncbi.nlm.nih.gov/pubmed/24015113 (https://www.ncbi.nlm.nih.gov/pubmed/24015113)
Pringsheim, T., et al. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord, 2014. 29: 1583. (https://www.ncbi.nlm.nih.gov/pubmed/24015113)https://www.ncbi.nlm.nih.gov/pubmed/24976103 (https://www.ncbi.nlm.nih.gov/pubmed/24976103)
Ragab, M.M., et al. Idiopathic Parkinson’s disease patients at the urologic clinic. Neurourol Urodyn, 2011. 30: 1258. (https://www.ncbi.nlm.nih.gov/pubmed/24976103)
Sakakibara, R., et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn, 2015. https://www.ncbi.nlm.nih.gov/pubmed/25810035
Dolecek, T.A., et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol, 2012. 14 Suppl 5: v1. https://www.ncbi.nlm.nih.gov/pubmed/23095881
Maurice-Williams, R.S. Micturition symptoms in frontal tumours. J Neurol Neurosurg Psychiatry, 1974. 37: 431. https://www.ncbi.nlm.nih.gov/pubmed/4365244
Christensen, D., et al. Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol, 2014. 56: 59. https://www.ncbi.nlm.nih.gov/pubmed/24117446
Marciniak, C., et al. Urinary incontinence in adults with cerebral palsy: prevalence, type, and effects on participation. PM R, 2014. 6: 110. https://www.ncbi.nlm.nih.gov/pubmed/23978464
Tagliaferri, F., et al. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien), 2006. 148: 255. https://www.ncbi.nlm.nih.gov/pubmed/16311842
Kulakli, F., et al. Relationship between urinary dysfunction and clinical factors in patients with traumatic brain injury. Brain Inj, 2014. 28: 323. https://www.ncbi.nlm.nih.gov/pubmed/24377376
Singh, A., et al. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol, 2014. 6: 309. https://www.ncbi.nlm.nih.gov/pubmed/25278785
Weld, K.J., et al. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology, 2000. 55: 490. https://www.ncbi.nlm.nih.gov/pubmed/10736489
Kondo, A., et al. Neural tube defects: prevalence, etiology and prevention. Int J Urol, 2009. 16: 49. https://www.ncbi.nlm.nih.gov/pubmed/19120526
Sawin, K.J., et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr, 2015. 166: 444. https://www.ncbi.nlm.nih.gov/pubmed/25444012
Bartolin, Z., et al. Relationship between clinical data and urodynamic findings in patients with lumbar intervertebral disk protrusion. Urol Res, 2002. 30: 219. https://www.ncbi.nlm.nih.gov/pubmed/12202938
Lange, M.M., et al. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol, 2011.8: 51. https://www.ncbi.nlm.nih.gov/pubmed/21135876
Daneshgari F1, Liu G, Birder L, Hanna-Mitchell AT, Chacko S Diabetic bladder dysfunction: current translational knowledge. J Urol. 2009 Dec;182(6 Suppl):S18-26. doi: 10.1016/j.juro.2009.08.070.
Yuan, Z., et al. Diabetic cystopathy: A review. J Diabetes, 2015. 7: 442. https://www.ncbi.nlm.nih.gov/pubmed/25619174
Pugliatti, M., et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol, 2006. 13: 700. https://www.ncbi.nlm.nih.gov/pubmed/16834700
de Seze, M., et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler, 2007. 13: 915. https://www.ncbi.nlm.nih.gov/pubmed/17881401
Лопаткин Н.А. (ред.) Руководство по урологии. Том 2. М.: Медицина, 1998. - 768 с. - ISBN 5-225-04435-2.
Del Popolo, G., et al. Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci, 2008. 29 Suppl 4: S352. https://www.ncbi.nlm.nih.gov/pubmed/19089675
Bors, E., et al. History and physical examination in neurological urology. J Urol, 1960. 83:759. (https://www.ncbi.nlm.nih.gov/pubmed/19089675)
Klausner, A.P., et al. The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am, 2011. 95: 111 (https://www.ncbi.nlm.nih.gov/pubmed/13802958)
Massa, L.M., et al. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. J Spinal Cord Med, 2009. 32: 568. https://www.ncbi.nlm.nih.gov/pubmed/20025153
Cameron, A.P., et al. The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder. J Urol, 2015. https://www.ncbi.nlm.nih.gov/pubmed/25956470
Honjo, H., et al. Impact of convenience void in a bladder diary with urinary perception grade to assess overactive bladder symptoms: a community-based study. Neurourol Urodyn, 2010. 29: 1286. https://www.ncbi.nlm.nih.gov/pubmed/20878998
Tsang, B., et al. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder. Neurourol Urodyn, 2015. https://www.ncbi.nlm.nih.gov/pubmed/25620137 (https://www.ncbi.nlm.nih.gov/pubmed/25620137)
Tudor K. I., Sakakibara R., Panicker J. N. Neurogenic lower urinary tract dysfunction: evaluation and management //Journal of neurology. – 2016. – Т. 263. – №. 12. – С. 2555-2564.
Vodusek, D.B. Lower urinary tract and sexual dysfunction in neurological patients. Eur Neurol, 2014.72: 109. https://www.ncbi.nlm.nih.gov/pubmed/24993182
Labat, J.J., et al. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn, 2008. 27: 306. https://www.ncbi.nlm.nih.gov/pubmed/17828787
Ouyang, L., et al. Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system. J Urol, 2015. 193: 558. https://www.ncbi.nlm.nih.gov/pubmed/25167993
Thietje, R., et al. Mortality in patients with traumatic spinal cord injury: descriptive analysis of 62 deceased subjects. J Spinal Cord Med, 2011. 34: 482. https://www.ncbi.nlm.nih.gov/pubmed/22118255
Лопаткин Н.А. Урология. Клинические рекомендации (2-е издание). — М.: ГЭОТАР-Медиа, 2013. — 416 с
Mukai, S., et al. Retrospective study for risk factors for febrile UTI in spinal cord injury patients with routine concomitant intermittent catheterization in outpatient settings. Spinal Cord, 2016. 54: 69. https://www.ncbi.nlm.nih.gov/pubmed/26458969
Nicolle, L., et al. Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Clinical Infectious Diseases 2005; 40:643–54. https://academic.oup.com/cid/article/40/5/643/363229
Goldmark E, Niver B, Ginsberg DA. Neurogenic bladder: from diagnosis to management. Curr Urol Rep. 2014;15(10):448
Przydacz M, Chlosta P, Corcos J. Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury. Int Urol Nephrol. 2018 Jun;50(6):1005-1016. doi: 10.1007/s11255-018-1852-7. Epub 2018 Mar 22. Review. PubMed PMID: 29569211
Пушкарь Д.Ю., Касян Г.Р., Функциональная урология и уродинамика (монография) – М, 2013. – 375 с.
Schafer, W., et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn, 2002. 21: 261. https://www.ncbi.nlm.nih.gov/pubmed/11948720
Bellucci, C.H., et al. Neurogenic lower urinary tract dysfunction--do we need same session repeat urodynamic investigations? J Urol, 2012. 187: 1318. https://www.ncbi.nlm.nih.gov/pubmed/22341264
Pannek, J., et al. Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: Urodynamics made easy? World J Urol, 2013. 31: 659. https://www.ncbi.nlm.nih.gov/pubmed/23073657 (https://www.ncbi.nlm.nih.gov/pubmed/23073657)
Ozkan, B., et al. Which factors predict upper urinary tract deterioration in overactive neurogenic bladder dysfunction? Urology, 2005. 66: 99. https://www.ncbi.nlm.nih.gov/pubmed/15992868 (https://www.ncbi.nlm.nih.gov/pubmed/23073657)
Podnar, S., et al. Lower urinary tract dysfunction in patients with peripheral nervous system lesions. Handb Clin Neurol, 2015. 130: 203. https://www.ncbi.nlm.nih.gov/pubmed/26003246 (https://www.ncbi.nlm.nih.gov/pubmed/23073657)
Chamberlain, J.D., et al. Mortality and longevity after a spinal cord injury: systematic review and meta-analysis. Neuroepidemiology, 2015. 44: 182. https://www.ncbi.nlm.nih.gov/pubmed/25997873 (https://www.ncbi.nlm.nih.gov/pubmed/23073657)
Madersbacher, H., et al. Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord, 2013. 51: 432. https://www.ncbi.nlm.nih.gov/pubmed/23743498
(https://www.ncbi.nlm.nih.gov/pubmed/23073657)
Patel DP, Lenherr SM, Stoffel JT, Elliott SP, Welk B, Presson AP, Jha A, Rosenbluth J, Myers JB; Neurogenic Bladder Research Group. Study protocol: patient reported outcomes for bladder management strategies in spinal cord injury. BMC Urol. 2017 Oct 10;17(1):95. doi: 10.1186/s12894-017-0286-3. PMID: 29017505; PMCID: PMC5635498.
Jaggi A, Drake M, Siddiqui E, Fatoye F. A comparison of the treatment recommendations for neurogenic lower urinary tract dysfunction in the national institute for health and care excellence, European Association of Urology and international consultations on incontinence guidelines. Neurourol Urodyn. 2018 Sep;37(7):2273-2280. doi: 10.1002/nau.23581. Epub 2018 Apr 17. PMID: 29664124,
Drake, M., et al., Conservative management in neuropathic urinary incontinence, in Incontinence, P. Abrams, L. Cardozo, S. Khoury & A. Wein, Editors. 2013, Health Publication: Plymouth:, 2013; pp. 827-1000 (https://www.ncbi.nlm.nih.gov/pubmed/23073657)
Kiddoo, D., et al. Randomized Crossover Trial of Single Use Hydrophilic Coated vs Multiple Use Polyvinylchloride Catheters for Intermittent Catheterization to Determine Incidence of Urinary Infection. J Urol, 2015. 194: 174. (https://www.ncbi.nlm.nih.gov/pubmed/23073657)https://www.ncbi.nlm.nih.gov/pubmed/25584995 (https://www.ncbi.nlm.nih.gov/pubmed/25584995)
Feng D, Cheng L, Bai Y, Yang Y, Han P. Outcomes comparison of hydrophilic and non-hydrophilic catheters for patients with intermittent catheterization: An updated meta-analysis. Asian J Surg. 2020 May;43(5):633-635. doi: 10.1016/j.asjsur.2019.12.009. Epub 2020 Jan 18. PMID: 31959575.
Park, Y.I., et al. A method to minimize indwelling catheter calcification and bladder stones in individuals with spinal cord injury. J Spinal Cord Med, 2001. 24: 105. https://www.ncbi.nlm.nih.gov/pubmed/11587416 (https://www.ncbi.nlm.nih.gov/pubmed/25584995)
Kabay SC, Yucel M, Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic det-rusor overactivity in patients with multiple sclerosis: Urodynamic study. Urology 2008;71:641-5. (https://doi.org/10.1016/j.urology.2007.11.135)
de Sèze M, Raibaut P, Gallien P, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: Results of a multicentre prospective study. Neurourol Urodyn 2011;30:306-11. https://doi.org/10.1002/nau.20958
Gross, T., et al. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. Eur Urol, 2016. 69: 1102.(https://www.ncbi.nlm.nih.gov/pubmed/25584995)http://www.europeanurology.com/article/S0302-2838(16)00061- 0/abstract/ (http://www.europeanurology.com/article/S0302-2838(16)00061-0/abstract/)
Priya Madhuvrata , Manju Singh, Zaid Hasafa, Mohamed Abdel-Fattah, Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis, Eur Urol . 2012 Nov;62(5):816-30. doi: 10.1016/j.eururo.2012.02.036.
Horstmann, M., et al. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol Urodyn, 2006. 25: 441. https://www.ncbi.nlm.nih.gov/pubmed/16847942 (https://www.ncbi.nlm.nih.gov/pubmed/22397851)
Bennett, N., et al. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol, 2004. 171: 749. https://www.ncbi.nlm.nih.gov/pubmed/14713802 (https://www.ncbi.nlm.nih.gov/pubmed/22397851)
Kosilov KV, Loparev SA, Ivanovskaya MA, Kosilova LV. Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women. Urol Int. 2014;93(4):470-3. doi: 10.1159/000363658. Epub 2014 Aug 28. PMID: 25170796.
Isik, A.T., et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging, 2009. 13: 672. https://www.ncbi.nlm.nih.gov/pubmed/19657549 (https://www.ncbi.nlm.nih.gov/pubmed/)
Barendrecht, M.M., et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence- based? BJU Int, 2007. 99: 749. https://www.ncbi.nlm.nih.gov/pubmed/17233798 (https://www.ncbi.nlm.nih.gov/pubmed/)
OʼRiordan JI, Doherty C, Javed M, Brophy D, Hutchinson M, Quinlan D. Do alpha‐blockers have a role in lower urinary tract dysfunction in multiple sclerosis? JUrol. 1995;153(4):1114‐1116.
Kakizaki H, Ameda K, Kobayashi S, Tanaka H, Shibata T, Koyanagi T. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder. Int J Urol. 2003 Nov;10(11):576-81. doi: 10.1046/j.1442-2042.2003.00710.x. PMID: 14633081.
Abrams P, Amarenco G, Bakke A, Buczyński A, Castro-Diaz D, Harrison S, Kramer G, Marsik R, Prajsner A, Stöhrer M, Van Kerrebroeck P, Wyndaele JJ; European Tamsulosin Neurogenic Lower Urinary Tract Dysfunction Study Group. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol. 2003 Oct;170(4 Pt 1):1242-51. doi: 10.1097/01.ju.0000084623.65480.f8. PMID: 14501734.
Lee KS, Han DH, Lee YS, Choo MS, Yoo TK, Park HJ, Yoon H, Jeong H, Lee SJ, Kim H, Park WH. Efficacy and safety of tamsulosin for the treatment of non- neurogenic voiding dysfunction in females: a 8-week prospective study. J Korean Med Sci. 2010 Jan;25(1):117-22. doi: 10.3346/jkms.2010.25.1.117. Epub 2009 Dec 26. PMID: 20052356; PMCID: PMC2800025.
Stankovich EIu, Borisov VV, Demina TL. Tamsulozin v lechenii detrzorno- sfinkternoĭ dissinergii mochevogo puzyria u bol'nykh rasseiannym sklerozom [Tamsulosin in the treatment of detrusor-sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis]. Urologiia. 2004 Jul-Aug;(4):48-51. Russian. PMID: 15457955.
Welk B, Hickling D, McKibbon M, Radomski S, Ethans K. A pilot randomized- controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2018 Nov;37(8):2810-2817. doi: 10.1002/nau.23774. Epub 2018 Aug 31. PMID: 30168626.
Krhut J, Borovička V, Bílková K, Sýkora R, Míka D, Mokriš J, Zachoval R. Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2018 Sep;37(7):2226-2233. doi: 10.1002/nau.23566. Epub 2018 Mar 31. Erratum in: Neurourol Urodyn. 2024 Jan;43(1):301. doi: 10.1002/nau.25272. PMID: 29603781.
Zhang D, Sun F, Yao H, Bao X, Wang D, Cui Y, Wu J. The Efficacy and Safety of Mirabegron for the Treatment of Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Meta-analysis. Front Pharmacol. 2021 Nov 18;12:756582. doi: 10.3389/fphar.2021.756582. PMID: 34867373; PMCID: PMC8636815.
Krebs J, Pannek J, Rademacher F, Wöllner J. Real-World Effects of Mirabegron in Patients with Chronic Neurogenic Detrusor Overactivity - A Retrospective Cohort Study. Res Rep Urol. 2020 May 22;12:187-192. doi: 10.2147/RRU.S253713. PMID: 32548077; PMCID: PMC7250696.
Everaert, K., et al. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg, 2009. 64: 335. https://www.ncbi.nlm.nih.gov/pubmed/19810421 (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
D’Hondt, F., et al. Urinary tract infections in patients with spinal cord injuries. Curr Infect Dis Rep, 2011. 13: 544. https://www.ncbi.nlm.nih.gov/pubmed/21853416 (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
Biering-Sorensen, F., et al. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs, 2001. 61: 1275. https://www.ncbi.nlm.nih.gov/pubmed/11511022 (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
Cruz, F., et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind,placebo-controlled trial. Eur Urol, 2011. 60: 742. (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
Schurch, B., et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol, 2005. 174: 196. https://www.ncbi.nlm.nih.gov/pubmed/15947626 (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
Mangera, A., et al. An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol, 2014. 65: 981. https://www.ncbi.nlm.nih.gov/pubmed/24239446 (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
Averbeck, M.A., et al. Follow-up of the neuro-urological patient: a systematic review. BJU Int, 2015. 115 Suppl 6: 39. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675201)https://www.ncbi.nlm.nih.gov/pubmed/ (https://www.ncbi.nlm.nih.gov/pubmed/)
Huang, M., et al. Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia. Journal of Rehabilitation Medicine, 2016. 48(8), 683–687.doi:10.2340/16501977-2132 (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
Schurch, B., et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol, 1996. 155: 1023. https://www.ncbi.nlm.nih.gov/pubmed/8583552 (https://www.ncbi.nlm.nih.gov/pubmed/25627993)
5 - Dykstra DD, Sidi AA. Treatment of detrusor‐sphincter dyssynergia with botulinum A toxin: a double‐blind study. Archives of Physical Medicine and Rehabilitation 1990;71(1):24‐6.
El-Azab, A.S., et al. Midurethral slings versus the standard pubovaginal slings for women with neurogenic stress urinary incontinence. Int Urogynecol J, 2015. 26: 427.(https://www.ncbi.nlm.nih.gov/pubmed/25627993)https://www.ncbi.nlm.nih.gov/pubmed/25315169 (https://www.ncbi.nlm.nih.gov/pubmed/25315169)
Vainrib M., Reyblat P., Ginsberg D.A. Long-term efficacy of repeat incisions of bladder neck/external sphincter in patients with spinal cord injury. Urology. 2014;84:940–945. doi: 10.1016/j.urology.2014.06.009.,
Ginsberg D.A., Boone T.B., Cameron A.P., Gousse A., Kaufman M.R., Keays E., Kennelly M.J., Lemack G.E., Rovner E.S., Souter L.H., et al. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up. J. Urol. 2021;206:1106–1113. doi: 10.1097/JU.0000000000002239..
Chancellor MB, Bennett C, Simoneau AR, Finocchiaro MV, Kline C, Bennett JK, et al. Sphincteric stent versus external sphincterotomy in spinal cord injured men: prospective randomized multicenter trial. Journal of Urology 1999;161(6):1893‐8
Abdul-Rahman, A., et al. Long-term outcome of tension-free vaginal tape for treating stress incontinence in women with neuropathic bladders. BJU Int, 2010. 106: 827. https://www.ncbi.nlm.nih.gov/pubmed/20132201 (https://www.ncbi.nlm.nih.gov/pubmed/25315169)
Elliott, D.S., et al. Mayo Clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: a review of 323 cases. J Urol, 1998. 159: 1206. https://www.ncbi.nlm.nih.gov/pubmed/9507835 (https://www.ncbi.nlm.nih.gov/pubmed/25315169)
Weld, K.J., et al. Effect of bladder management on urological complications in spinal cord injured patients. J Urol, 2000. 163: 768. https://www.ncbi.nlm.nih.gov/pubmed/10687973 (https://www.ncbi.nlm.nih.gov/pubmed/25315169)
Stohrer M, Castro-Diaz D, Chartier-Kastler E, et al. Guidelines on neurogenic lower urinary tract dysfunction. Prog Urol. 2007;17:703–55
6th International Consultation on Incontinence. Neurologic Urinary and Fecal Incontinence. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence. 16 ed. International Continence Society; 2017. pp. 1093–308
Gor RA, Elliott SP. Surgical management of neurogenic lower urinary tract dysfunction. Urol Clin North Am. 2017;44:475–90. doi: 10.1016/j.ucl.2017.04.013
Game X, Karsenty G, Chartier-Kastler E, et al. [Treatment of neurogenic detrusor hyperactivity: enterocystoplasty]. Prog Urol. 2007;17:584–96. doi: 10.1016/S1166-90
Chen Z, Lu G, Li X, Li X, Fang Q, Ji H, et al. Better compliance contributes to better nocturnal continence with orthotopic ileal neobladder than ileocolonic neobladder after radical cystectomy for bladder cancer. Urology 2009;73(4):838‐43; discussion 843‐4,
Khafagy M, Shaheed FA, Moneim TA. Ileocaecal vs ileal neobladder after radical cystectomy in patients with bladder cancer: a comparative study. BJU International 2006;97(4):799‐804,
Kristjansson A, Bajc M, Wallin L, Willner J, Mansson W. Renal function up to 16 years after conduit (refluxing or anti‐reflux anastomosis) or continent urinary diversion. 2. Renal scarring and location of bacteriuria. British Journal of Urology 1995;76:546‐50. [MEDLINE: ],
Shaaban AA, Abdel‐Latif M, Mosbah A, Gad H, Eraky I, Ali‐El‐Dein B, et al. A randomized study comparing an antireflux system with a direct ureteric anastomosis in patients with orthotopic ileal neobladders. BJU International 2006;97(5):1057‐62. ].
Реабилитация больных с травматической болезнью спинного мозга. Руководство / под общ. ред. Г.Е. Ивановой [и др.]. – М., 2010. – 640 с. (https://www.ncbi.nlm.nih.gov/pubmed/25315169)
Getliffe K, Fader M, Cottenden A, Jamieson K, Green N. Absorbent products for incontinence: 'treatment effects' and impact on quality of life. J Clin Nurs. 2007 Oct;16(10):1936-45. doi: 10.1111/j.1365-2702.2007.01812.x. PMID: 17880482.
Miget G, Moutounaick M, Kervinio F, Teng M, Chesnel C, Charlanes A, Le Breton F, Amarenco G. Place des protections dans la prise en charge de l’incontinence urinaire [Absorbent products for urinary incontinence management]. Prog Urol. 2018 Dec;28(17):953-961. French. doi: 10.1016/j.purol.2018.08.017. Epub 2018 Oct 22. PMID: 30361139].
Li, L., et al. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil, 2013. 94: 782.
https://www.ncbi.nlm.nih.gov/pubmed/23168400 (https://www.ncbi.nlm.nih.gov/pubmed/20950307)
Tibaek S., et al. Is Pelvic Floor Muscle Training Effective for Men With Poststroke Lower Urinary Tract Symptoms? A Single-Blinded Randomized, Controlled Trial. Am J Mens Health. 2017 Sep;11(5):1460-1471. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675201)
Shin DC, Shin SH, Lee MM, Lee KJ, Song CH. Pelvic floor muscle training for urinary incontinence in female stroke patients: a randomized, controlled and blinded trial. Clin Rehabil. 2016 Mar;30(3):259-67. doi:10.1177/0269215515578695 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675201)
Averbeck, M.A., et al. Follow-up of the neuro-urological patient: a systematic review. BJU Int, 2015. 115 Suppl 6: 39. https://www.ncbi.nlm.nih.gov/pubmed/
Wan D., et al. Life-threatening outcomes associated with autonomic dysreflexia: a clinical review. J Spinal Cord Med. 2014 Jan;37(1):2-10. doi: 10.1179/2045772313Y.0000000098
Liu N., et al. Autonomic dysreflexia severity during urodynamics and cystoscopy in individuals with spinal cord injury. Spinal Cord, 2013. 51: 863. https://www.ncbi.nlm.nih.gov/pubmed/24060768